Philadelphia, PA
,
USA
·
North America
SR One is a Philadelphia-based healthcare venture capital firm originally established as the corporate venture arm of GlaxoSmithKline. The firm invests $5M–$25M at Series A and B stage in biotechnology and pharmaceutical companies. Portfolio companies include CytomX, Goldfinch Bio, Imago BioSciences, and Passage Bio.
Know when they open it, which slides they read, and when to follow up.
Pitchwise turns every shared deck into a live intelligence feed.
